Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.7K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.7K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

1.1K
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

7.5K
The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
7.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adalimumab Biosimilars and Access Barriers in Dermatology.

Journal of the American Academy of Dermatologyยท2026
Same author

Redo-TAVR (TAV-in-TAV) Best Practices Part 1: Short-in-Short and Short-in-Tall - A Heart and Valve Collaboratory Document.

JACC. Cardiovascular interventionsยท2026
Same author

Redo-TAVR (TAV-in-TAV) Best Practices Part 2: Tall-in-Short and Tall-in-Tall - A Heart and Valve Collaboratory Document.

JACC. Cardiovascular interventionsยท2026
Same author

Preemptive cardioprotection with a small molecule in rodents that suppresses genes predictive of heart failure.

Science advancesยท2026
Same author

Ethnicity and its impact on presentation and outcomes in patients with spontaneous coronary artery dissection from the Australian-New Zealand registry.

Heart (British Cardiac Society)ยท2026
Same author

A methodological framework for validating a multi-domain physiological sensor for divers using a scalable data fusion platform.

Frontiers in physiologyยท2026
Same journal

Smartwatch-Based Heart Rate Detection in Atrial, Ventricular and Pulseless Arrhythmias.

Heart, lung & circulationยท2026
Same journal

Global, Regional and National Burden of Pulmonary Arterial Hypertension in Young and Middle-Aged Adults, 1990-2021, with Projections to 2045.

Heart, lung & circulationยท2026
Same journal

2026 Update of the Core Components of Cardiovascular Rehabilitation: A Position Statement From the Australian Cardiovascular Health and Rehabilitation Association (ACRA).

Heart, lung & circulationยท2026
Same journal

Outcomes Selected by Pressure Wire in Coronary Artery Revascularisation: The OSCAR Study.

Heart, lung & circulationยท2026
Same journal

Coagulopathy in Cardiac Surgery: A Scoping Review of Prothrombin Complex Concentrate.

Heart, lung & circulationยท2026
Same journal

Low Albumin and Elevated FIB-4 Are Associated With Adverse Outcomes After the Fontan Procedure.

Heart, lung & circulationยท2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Machine Learning for Cardiovascular Risk Prediction: A Practical Primer for Clinicians.

Hari P Sritharan1, Harrison Nguyen2, Usaid K Allahwala3

  • 1Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia.

Heart, Lung & Circulation
|April 18, 2026
PubMed
Summary
This summary is machine-generated.

Machine learning (ML) enhances clinical risk prediction beyond traditional methods. This guide covers ML model development, validation, and implementation for cardiovascular research and practice.

Keywords:
Artificial intelligenceCardiologyEpidemiologyMachine learning

Related Experiment Videos

Last Updated: Apr 20, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Machine learning (ML) is increasingly vital in clinical risk prediction, offering superior pattern recognition and predictive power compared to traditional statistical methods.
  • Its application in cardiovascular research and clinical practice is rapidly expanding, necessitating a foundational understanding of its methodologies.

Purpose of the Study:

  • To provide a foundational understanding of ML methodology for clinical risk prediction.
  • To guide readers in developing, validating, and implementing ML models in healthcare.
  • To address challenges and offer practical recommendations for using ML in clinical practice.

Main Methods:

  • Discussion of supervised and unsupervised learning approaches.
  • Explanation of feature selection and performance metrics.
  • Overview of advanced techniques like deep learning and interrupted time-series analysis.

Main Results:

  • Exploration of ML's enhanced pattern recognition and predictive capabilities in risk assessment.
  • Identification of key considerations for model development, validation, and implementation.
  • Analysis of challenges including interpretability, bias, and clinical integration.

Conclusions:

  • This primer equips readers to critically evaluate ML-based risk prediction models.
  • It fosters effective collaboration between clinicians and data scientists.
  • It supports the informed adoption of ML tools in cardiovascular care.